Ticker Details
Zentalis Pharmaceuticals, Inc.
IPO Date:	April 3, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$313.52M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.81 | 3.56%
Avg Daily Range (30 D):	$0.24 | 8.27%
Avg Daily Range (90 D):	$0.15 | 5.61%

Institutional Daily Volume
Avg Daily Volume:	.67M
Avg Daily Volume (30 D):	2.3M
Avg Daily Volume (90 D):	1.6M

Trade Size
Avg Trade Size (Sh.):	95
Avg Trade Size (Sh.) (30 D):	160
Avg Trade Size (Sh.) (90 D):	171

Institutional Trades
Total Institutional Trades:	1,923
Avg Institutional Trade:	$2.09M
Avg Institutional Trade (30 D):	$.63M
Avg Institutional Trade (90 D):	$1.43M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.74M
Avg Closing Trade (30 D):	$.7M
Avg Closing Trade (90 D):	$.7M
Avg Closing Volume:	121.35K

News

Apr 1, 2026 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Na

Jan 12, 2026 @ 3:35 PM Fast-Tracking the $537B Cancer Cure: How Accelerat... Source: Prnewswire

Dec 17, 2025 @ 2:00 PM Incyclix Bio Expands Board of Directors with Appoi... Source: Tony Plohoros

Sep 2, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Aron Feingold

Aug 7, 2025 @ 12:28 AM Zentalis (ZNTL) Q2 Loss Narrows 70% Source: Jesterai

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.91	$-.49	$-1.91
Diluted EPS	$-1.91	$-.49	$-1.91
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-137.06M	$-35.22M	$-137.06M
Operating Income / Loss	$-152.81M	$-37.39M	$-152.81M
Cost of Revenue
Net Cash Flow	$2.09M	$-3.08M	$2.09M
PE Ratio